1st Quarter - Amendment

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2025 $120,000 Replaced
1st Quarter - Amendment (this page) Jul 16, 2025 $120,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Layoffs at health agencies -Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842) -Telehealth -Centers for Disease Control and Preventions Division for Heart Disease and Stroke Prevention (CDC/DHDSP) -Retirement and Disability Research Consortium (RDRC) program at SSA -Older Americans Act -National Advisory Council on Aging at NIH

LobbyistCovered position, as disclosed
ADINA ROSE LASSER New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Social Security Administration (SSA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Executive Office of the President (EOP)

Bills named: H.R. 842 (119th)

Medicare/Medicaid MMM

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Anti-obesity medications -Medicaid and the Supplemental Nutrition Assistance Program (SNAP)

LobbyistCovered position, as disclosed
SCOTT FREY New Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

-FY26 report language for the Food and Drug Administration -FY26 report language for the Medicare Program -FY26 report language for the Medicare Prescription Payment Plan -FY26 NIH funding

LobbyistCovered position, as disclosed
ADINA ROSE LASSER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.